Purdue Pharma sues Amneal over OxyContin
sprng23 / iStockphoto.com
A patent dispute over a generic version of Purdue Pharma’s drug OxyContin (oxycodone), which is used to treat moderate to severe pain, has come to an end.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Purdue Pharma, Amneal, OxyContin, ANDA, FDA, patent, patent infringement, oxycodone, dismissal